Teva Pharmaceutical Industries

Teva to buy Allergan generic drug business for $40.5 billion, drops Mylan bid

Teva Pharmaceutical Industries has agreed to buy Allergan Plc's generic drugs business for $40.5 billion in a cash and stock deal that will turn the Israeli company into one of the world's largest pharmaceutical firms.

Read Full Article

Teva to buy U.S. drug developer Auspex Pharma for $3.5 billion

Israel's Teva Pharmaceutical Industries said it would buy U.S. neurology drug company Auspex Pharmaceuticals Inc for an equity value of $3.5 billion to boost its portfolio of treatments for the central nervous system.

Read Full Article

Israel-based drugmaker Teva Pharmacuetical Industries is Soros' single largest stockholding

The single largest stock holding of Soros Fund Management in the fourth quarter is Israeli drugmaker Teva Pharmaceutical Industries Ltd, Reuters reported citing a February 14 filing with the US Securities and Exchange Commission.

Read Full Article

Israel's Teva Pharmaceutical Industries names Erez Vigodman as CEO

The world's largest generic drugmaker, Teva Pharmaceutical Industries Ltd, has chosen Erez Vigodman to become its President and Chief Executive Officer beginning February 11, Bloomberg reported.

Read Full Article

Report says Teva Pharmaceutical Industries to name Erez Vigodman as new CEO

TheMarker, a financial news website, said generic drugmaker Teva Pharmaceutical Industries is set to name Erez Vigodman as its new Chief Executive on January 13 at the JPMorgan Healthcare Conference in San Francisco, Reuters reported.

Read Full Article

Teva Pharm top huncho Levin resigns

CEO Jeremy Levin resigns from Teva, but board is confident they will find a permanent replacement.

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics